BERTOLINO, Arthur P., MD, PhD
To:Cellceutix Corp., Pres. & CMO (June)
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
BERTOLINO, Arthur P., MD, PhD
To:Cellceutix Corp., Pres. & CMO (June)
Aneesh Karatt-Vellatt is leading the charge to redefine how ion channels and G protein-coupled receptors (GPCRs) are targeted with antibody therapies, one of the most notoriously challenging classes of drug targets.
In the latest podcast interview, Phil L'Huillier, CEO of Scancell, discussed the company's work in cancer vaccine development, and its selection as the first British biotech to be a part of the NHS Cancer Vaccine Launch Pad.
New report by global law firm Taylor Wessing and Bayes Business School forecasts a steadily increasing volume of major life sciences M&A in the coming five years, but highlights concerns over cybersecurity and unrealistic valuations. Taylor Wessing partner Andrew Edge spoke to In Vivo.